ASTM E2475-10 - 15.4.2010
 
1. Scope

1.1 The purpose of this guide is to establish a framework and context for process understanding for pharmaceutical manufacturing using quality by design (QbD) (Juran, 1992; FDA/ICH Q8). The framework is applicable to both active pharmaceutical ingredient (API) and to drug product (DP) manufacturing. High (detailed) level process understanding can be used to facilitate production of product which consistently meets required specifications. It can also play a key role in continuous process improvement efforts.

1.2 Process Analytical Technology (PAT) is one element that can be used for achieving control over those inputs determined to be critical to a process. It is important for the reader to recognize that PAT is defined as:

 
2. Referenced Documents

E456-13a(2022)

Standard Terminology Relating to Quality and Statistics (Includes all amendments and changes 4/21/2022).

U.S.FDAPAT

Pharmaceutical Quality Systems

FDA/ICHQ8

E2281-15(2020)

Standard Practice for Process Capability and Performance Measurement

E2617-17

Standard Practice for Validation of Empirically Derived Multivariate Calibrations

E2474-14

Standard Practice for Pharmaceutical Process Design Utilizing Process Analytical Technology (Withdrawn 2020)